Therese Törngren
Lund University(SE)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Melanoma and MAPK Pathways, BRCA gene mutations in cancer, Computational Drug Discovery Methods, Protein Degradation and Inhibitors
Most-Cited Works
- → Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma(2017)486 cited
- → Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy(2015)191 cited
- → Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic(2016)146 cited
- → NF1‐mutated melanoma tumors harbor distinct clinical and biological characteristics(2017)132 cited
- → Characterization ofBRCA1andBRCA2deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study(2010)125 cited
- → Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma(2012)108 cited
- → Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma(2016)103 cited
- → Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility(2017)92 cited
- → Genome-wide RNAi Screen Identifies Cohesin Genes as Modifiers of Renewal and Differentiation in Human HSCs(2016)79 cited
- → Molecular and genetic diversity in the metastatic process of melanoma(2014)68 cited